APA (7th ed.) Citation

QY, H., L, L., YH, L., HB, Z., T, D., Y, L., . . . Y, C. (2025). A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth. Acta pharmacologica Sinica, 46(3), 740. https://doi.org/10.1038/s41401-024-01394-6

Chicago Style (17th ed.) Citation

QY, Hu, Li L, Li YH, Zhang HB, Deng T, Liu Y, Li FT, Xiao ZX, and Cao Y. "A Structure-based Virtual Screening Identifies a Novel MDM2 Antagonist in the Activation of the P53 Signaling and Inhibition of Tumor Growth." Acta Pharmacologica Sinica 46, no. 3 (2025): 740. https://doi.org/10.1038/s41401-024-01394-6.

MLA (9th ed.) Citation

QY, Hu, et al. "A Structure-based Virtual Screening Identifies a Novel MDM2 Antagonist in the Activation of the P53 Signaling and Inhibition of Tumor Growth." Acta Pharmacologica Sinica, vol. 46, no. 3, 2025, p. 740, https://doi.org/10.1038/s41401-024-01394-6.